Nuvectis Pharma, Inc. (NVCT) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 2 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for NVCT is $10.00, representing a +14.5% upside from the current price of $8.73. Price targets range from a low of $10.00 to a high of $10.00.
